PRJNA523255
Sequencing data LIGS 2.0 against  CD3e-TCR complex
LIGS 2.0 introduces a new screening method to selectively identify synthetic ligands against cell-surface proteins in order to expand the repertoire of immunotherapeutic molecules against life-threatening diseases such as cancer and auto-immune diseases.